Could fasting boost breast cancer drugs? new study investigates
NCT ID NCT07624617
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at whether a special fasting schedule (eating only dinner) can make PI3K inhibitor drugs work better against metastatic breast cancer. Researchers will check if patients can stick with the fasting plan and study blood samples to see how fasting affects cancer cells in the lab. Only 15 people will take part, and the goal is to gather early clues, not to prove a new treatment.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
prolonged fasting (behavioral intervention)
What this could lead to
If successful, this could point toward a way to make existing cancer drugs work better by adding a fasting regimen.
What could go wrong
This is a very small, early-stage trial (15 people) that only measures biological markers, not patient outcomes. Fasting may be hard to tolerate and may not improve treatment effectiveness.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC BREAST CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of Minnesota
Minneapolis, Minnesota, 55455, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••